HealthInsights

Cancer has long been a formidable adversary in the field of medicine, affecting millions of lives worldwide. However, in recent years, revolutionary advancements in cancer treatment have brought hope to patients and healthcare professionals alike. One such breakthrough is the emergence of ENHERTU , a cutting-edge therapy with the potential to transform cancer management. In this blog, we will explore ENHERTU's journey in cancer treatment and its impact on various types of cancers. How is it different from other chemotherapy drugs? ENHERTU , developed by Daiichi Sankyo and AstraZeneca, belongs to a novel class of drugs known as antibody-drug conjugates (ADCs). Unlike traditional chemotherapy, which indiscriminately attacks both cancerous and healthy cells, ENHERTU is designed to deliver its payload selectively to cancer cells, minimizing damage to surrounding tissues. This targeted approach reduces the severity of side effects, enhancing the overall quality of life for patients duri...

Cancer is a devastating disease that affects millions of people worldwide. However, advancements in cancer treatment have brought about new hope for patients. One such advancement is ENHERTU , a cancer medication that has shown remarkable results in the treatment and management of various types of cancer. In this blog, we will explore ENHERTU's journey in cancer treatment and management, including its mechanism of action, designations, approvals, cost, and patient assistance. What is ENHERTU and How is it Used? ENHERTU is a type of cancer medication that is designed to treat HER2-positive breast cancer, gastric cancer, and non-small cell lung cancer. It is a type of antibody-drug conjugate that targets the HER2 protein on cancer cells, delivering a potent chemotherapy drug directly to the cancer cells while minimizing damage to healthy cells. ENHERTU is administered through intravenous infusion once every three weeks, and the dosage is dependent on the patient's body weight an...